CAMBRIDGE, Mass.--(BUSINESS WIRE)--PatientsLikeMe has named Marcia Nizzari Vice President of Engineering. In this role, Marcia creates the blueprint for future platform developments and oversees all engineering projects. A member of the management team, Marcia reports to Chief Operating Officer Sebastiaan Foppema.
“Marcia has joined the team at a time when we’re evolving our website to meet emerging patient needs and securing more partner projects,” said Foppema. “Her software expertise and technical management experience will be instrumental to ensuring we align our resources with the best interests of patients and partners.”
Marcia joined PatientsLikeMe from molecular diagnostics lab Good Start Genetics, where she was the Director of Bioinformatics and High Performance Computing/IT responsible for software engineering, informatics, and IT personnel. Before that, Marcia was Director of Informatics for the Program in Medical and Population Genetics at the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University. She has also held senior supervisory roles at Cambridge Research & Instrumentation (now part of PerkinElmer) and Thomson Financial. Marcia holds a Master of Science degree in Computer Science from Boston University and a Bachelor of Music degree in Performance from the New England Conservatory of Music.
PatientsLikeMe® (www.patientslikeme.com) is a patient network that improves lives and a real-time research platform that advances medicine. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences. In the process, they generate data about the real-world nature of disease that help researchers, pharmaceutical companies, regulators, providers, and nonprofits develop more effective products, services and care. PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 30 peer-reviewed research studies. Visit us at www.patientslikeme.com or follow us via our blog, Twitter or Facebook.